Stockreport

Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study [Yahoo! Finance]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF Enrollment in the ongoing Phase 2 trial of a drug to treat chronic spontaneous urticaria (CSU), or chronic hives, was paused. The biopharmaceutical firm also said it [Read more]